Skip to main content
. 2021 Dec 24;14(1):35. doi: 10.3390/pharmaceutics14010035

Figure 2.

Figure 2

Validation of the current model performance. (a) The numerically calculated IFP distribution was validated with the experimental data from the literature. (b) The comparison of obtained IFV values with the theoretical amounts of previously published studies. (c) The value of FKCs compared to experimental results obtained 60 h after conventional chemotherapy taken from previously published studies. (d) Temperature comparisons between numerical simulation and experimental results of MHT on murine under the same conditions. (e) Qualitative verifications of TSL-Dox delivery in the present study and those in the literature.